{
    "organizations": [],
    "uuid": "09984632fc5a17cab4ada26c7e06bdbc171d8398",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cti-biopharma-q4-loss-per-share-03/brief-cti-biopharma-q4-loss-per-share-0-33-idUSASB0C99A",
    "ord_in_thread": 0,
    "title": "BRIEF-CTI Biopharma Q4 Loss Per Share $0.33",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 7 (Reuters) - Cti Biopharma Corp:\n* CTI BIOPHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS\n* Q4 LOSS PER SHARE $0.33 * TOTAL REVENUES FOR Q4 WERE $0.46 MILLION COMPARED TO $9.1 MILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-08T05:37:00.000+02:00",
    "crawled": "2018-03-08T17:05:23.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "cti",
        "biopharma",
        "corp",
        "cti",
        "biopharma",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "q4",
        "loss",
        "per",
        "share",
        "total",
        "revenue",
        "q4",
        "million",
        "compared",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}